Skip to main content
OpenTrials

Clinical trial condition

Haemophilia B With Inhibitors

Explore clinical trials studying Haemophilia B With Inhibitors. Study availability and eligibility vary by location and protocol.

25 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Haemophilia B With Inhibitors trial results

Completed

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

NCT01561391

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Completed

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

NCT03741881

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Sacramento, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
View all 143 locations
View Trial Details
Completed

A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors

NCT03196284

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Indianapolis, Indiana, United States
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
  • Novo Nordisk Investigational Site Vienna, Austria
View all 22 locations
View Trial Details
Completed

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial

NCT02541942

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Tampa, Florida, United States
  • Novo Nordisk Investigational Site Atlanta, Georgia, United States
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
View all 15 locations
View Trial Details
Completed

Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors

NCT00951405

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Investigational Site Little Rock, Arkansas, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Orange, California, United States
  • Novo Nordisk Investigational Site Tampa, Florida, United States
View all 25 locations
View Trial Details
Completed

Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors

NCT01392547

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Clinical Trial Call Center Tucson, Arizona, United States
  • Novo Nordisk Clinical Trial Call Center Los Angeles, California, United States
  • Novo Nordisk Clinical Trial Call Center Los Angeles, California, United States
  • Novo Nordisk Clinical Trial Call Center Orange, California, United States
View all 32 locations
View Trial Details

Related conditions